125 related articles for article (PubMed ID: 37329551)
21. Genetic variations in cytotoxic T-lymphocyte antigen-4 and susceptibility to cervical cancer.
Xiong YH; He L; Fei J
Int Immunopharmacol; 2014 Jan; 18(1):71-6. PubMed ID: 24201079
[TBL] [Abstract][Full Text] [Related]
22. A pilot study on cytotoxic T lymphocyte-4 gene polymorphisms in urinary schistosomiasis.
Idris ZM; Yazdanbakhsh M; Adegnika AA; Lell B; Issifou S; Noordin R
Genet Test Mol Biomarkers; 2012 Jun; 16(6):488-92. PubMed ID: 22288822
[TBL] [Abstract][Full Text] [Related]
23. Association between cytotoxic T-lymphocyte antigen 4 gene polymorphisms and primary biliary cirrhosis in Chinese population: data from a multicenter study.
Li Q; Wang B; Pan F; Zhang R; Xiao L; Guo H; Ma S; Zhou C
J Gastroenterol Hepatol; 2013 Aug; 28(8):1397-402. PubMed ID: 23432218
[TBL] [Abstract][Full Text] [Related]
24. CTLA-4 polymorphisms are associated with treatment outcomes of patients with multiple myeloma receiving bortezomib-based regimens.
Qin XY; Lu J; Li GX; Wen L; Liu Y; Xu LP; Chang YJ; Liu KY; Jiang ZF; Huang XJ
Ann Hematol; 2018 Mar; 97(3):485-495. PubMed ID: 29264740
[TBL] [Abstract][Full Text] [Related]
25. CTLA-4 and MDR1 polymorphisms increase the risk for ulcerative colitis: A meta-analysis.
Zhao JJ; Wang D; Yao H; Sun DW; Li HY
World J Gastroenterol; 2015 Sep; 21(34):10025-40. PubMed ID: 26379408
[TBL] [Abstract][Full Text] [Related]
26. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
[TBL] [Abstract][Full Text] [Related]
27. CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.
Karabon L; Pawlak E; Tomkiewicz A; Jedynak A; Passowicz-Muszynska E; Zajda K; Jonkisz A; Jankowska R; Krzakowski M; Frydecka I
Hum Immunol; 2011 Oct; 72(10):947-54. PubMed ID: 21669243
[TBL] [Abstract][Full Text] [Related]
28. Association between the Rs3087243 polymorphism and risk for diabetes: a meta-analysis.
Liu J; Zhang HX
Genet Mol Res; 2013 Dec; 12(4):6344-50. PubMed ID: 24390983
[TBL] [Abstract][Full Text] [Related]
29. Association of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Gene Polymorphisms with Autoimmune Thyroid Disease in Children and Adults: Case-Control Study.
Ting WH; Chien MN; Lo FS; Wang CH; Huang CY; Lin CL; Lin WS; Chang TY; Yang HW; Chen WF; Lien YP; Cheng BW; Lin CH; Chen CC; Wu YL; Hung CM; Li HJ; Chan CI; Lee YJ
PLoS One; 2016; 11(4):e0154394. PubMed ID: 27111218
[TBL] [Abstract][Full Text] [Related]
30. Association between CTLA-4 polymorphisms and the susceptibility to systemic lupus erythematosus and Graves' disease in Thai population.
Kimkong I; Nakkuntod J; Sae-Ngow S; Snabboon T; Avihingsanon Y; Hirankarn N
Asian Pac J Allergy Immunol; 2011 Sep; 29(3):229-35. PubMed ID: 22053592
[TBL] [Abstract][Full Text] [Related]
31. Association and gene-gene interaction analyses for polymorphic variants in CTLA-4 and FOXP3 genes: role in susceptibility to autoimmune thyroid disease.
Fathima N; Narne P; Ishaq M
Endocrine; 2019 Jun; 64(3):591-604. PubMed ID: 30771152
[TBL] [Abstract][Full Text] [Related]
32. Association of CTLA-4 tagging polymorphisms and haplotypes with hepatocellular carcinoma risk: A case-control study.
Yang J; Liu J; Chen Y; Tang W; Liu C; Sun Y; Chen J
Medicine (Baltimore); 2019 Jul; 98(29):e16266. PubMed ID: 31335675
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma.
Liu Y; He Z; Feng D; Shi G; Gao R; Wu X; Song W; Yuan W
DNA Cell Biol; 2011 Dec; 30(12):1051-5. PubMed ID: 21612409
[TBL] [Abstract][Full Text] [Related]
34. hTERT gene polymorphism correlates with the risk and the prognosis of thyroid cancer.
Gong L; Xu Y; Hu YQ; Ding QJ; Yi CH; Huang W; Zhou M
Cancer Biomark; 2016 Jul; 17(2):195-204. PubMed ID: 27472887
[TBL] [Abstract][Full Text] [Related]
35. Strong association of CTLA-4 variation (CT60A/G) and CTLA-4 haplotypes with predisposition of Iranians to head and neck cancer.
Erfani N; Haghshenas MR; Hoseini MA; Hashemi SB; Khademi B; Ghaderi A
Iran J Immunol; 2012 Sep; 9(3):188-98. PubMed ID: 23023383
[TBL] [Abstract][Full Text] [Related]
36. CTLA-4 polymorphisms (+49 A/G and -318 C/T) are important genetic determinants of AITD susceptibility and predisposition to high levels of thyroid autoantibodies in Polish children - preliminary study.
Pastuszak-Lewandoska D; Domańska D; Rudzińska M; Bossowski A; Kucharska A; Sewerynek E; Czarnecka K; Migdalska-Sęk M; Czarnocka B
Acta Biochim Pol; 2013; 60(4):641-6. PubMed ID: 24364045
[TBL] [Abstract][Full Text] [Related]
37. Impacts of CD152 polymorphisms on cervical cancer susceptibility.
Cao S; Zheng L
Pathol Res Pract; 2020 Aug; 216(8):152918. PubMed ID: 32616425
[TBL] [Abstract][Full Text] [Related]
38. CTLA-4 gene polymorphisms associate with efficacy of postoperative radioiodine-131 for differentiated thyroid carcinoma.
Chang DF; Chen XH; Huang J; Sun YM; Zhu DY; Xu ZQ
Future Oncol; 2017 May; 13(12):1057-1068. PubMed ID: 28326838
[TBL] [Abstract][Full Text] [Related]
39. Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms.
Daroszewski J; Pawlak E; Karabon L; Frydecka I; Jonkisz A; Slowik M; Bolanowski M
Eur J Endocrinol; 2009 Nov; 161(5):787-93. PubMed ID: 19734241
[TBL] [Abstract][Full Text] [Related]
40. Association between SNPs of Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death 1 (PD-1)and the susceptibility to chronic Hepatitis C infection in virus C-infected patients.
Ali ESG; Bassyouni RH; Abdelaleem OO; Hassan EA; Gaber SN
Virus Res; 2022 Mar; 310():198684. PubMed ID: 35063794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
